Mutual Funds & ETF's
Treasury & Bonds
View Full List
Dow Jones Industrial Average
Standard & Poors 500
NYSE COMPOSITE INDX
(PSTI) Pluristem Therapeutics to Begin IC Phase II Trial
Stock Blog Hub
Posted on August 26, 2012 at 18:01 PM EDT
Pluristem Therapeutics, Inc. (PSTI) recently announced that it will be initiating phase II studies... Visit StockBlogHub to view complete post.
Read More >>
PLURISTEM THERAPEUTICS, Inc.
Protalix BioTherapeutics, Inc.
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Terms and Conditions
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Bots go here